M N Pakdaman1, G Ishiyama2, A Ishiyama3, K A Peng3, H J Kim1, W B Pope1, A R Sepahdari4. 1. From the Departments of Radiological Sciences (M.N.P., H.J.K., W.B.P., A.R.S.). 2. Neurology (G.I.). 3. Head and Neck Surgery (A.I., K.A.P.), David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California. 4. From the Departments of Radiological Sciences (M.N.P., H.J.K., W.B.P., A.R.S.) alisepahdari@gmail.com.
Abstract
BACKGROUND AND PURPOSE: Menière disease and idiopathic sudden sensorineural hearing loss can have overlapping clinical presentation and may have similar pathophysiology. Prior studies using postcontrast 3D-FLAIR MR imaging suggest abnormal blood-labyrinth barrier permeability in both conditions, but the 2 diseases have not been directly compared by using the same imaging techniques. We hypothesized that delayed postcontrast 3D-FLAIR MR imaging would show differences in blood-labyrinth barrier permeability between Menière disease and idiopathic sudden sensorineural hearing loss. MATERIALS AND METHODS: Patients with unilateral Menière disease (n = 32) and unilateral idiopathic sudden sensorineural hearing loss (n = 11) imaged with delayed postcontrast 3D-FLAIR MR imaging were retrospectively studied. Signal intensities of the medulla and perilymph of the cochlear basal turns of both ears in each patient were measured in a blinded fashion. Cochlea/medulla ratios were calculated for each ear as a surrogate for blood-labyrinth barrier permeability. The ears were segregated by clinical diagnosis. RESULTS: Cochlea/medulla ratio was higher in symptomatic ears of patients with Menière disease (12.6 ± 7.4) than in patients with idiopathic sudden sensorineural hearing loss (5.7 ± 2.0) and asymptomatic ears of patients with Menière disease (8.0 ± 3.1), indicating increased blood-labyrinth barrier permeability in Menière disease ears. The differences in cochlea/medulla ratio between symptomatic and asymptomatic ears were significantly higher in Menière disease than in idiopathic sudden sensorineural hearing loss. Asymptomatic ears in patients with Menière disease showed higher cochlea/medulla ratio than symptomatic and asymptomatic ears in patients with idiopathic sudden sensorineural hearing loss. CONCLUSIONS: Increased cochlea/medulla ratio indicates increased blood-labyrinth barrier permeability in Menière disease compared with idiopathic sudden sensorineural hearing loss. Increased cochlea/medulla ratio in asymptomatic ears of patients with Menière disease also suggests an underlying systemic cause of Menière disease and may provide a pathophysiologic biomarker.
BACKGROUND AND PURPOSE: Menière disease and idiopathic sudden sensorineural hearing loss can have overlapping clinical presentation and may have similar pathophysiology. Prior studies using postcontrast 3D-FLAIR MR imaging suggest abnormal blood-labyrinth barrier permeability in both conditions, but the 2 diseases have not been directly compared by using the same imaging techniques. We hypothesized that delayed postcontrast 3D-FLAIR MR imaging would show differences in blood-labyrinth barrier permeability between Menière disease and idiopathic sudden sensorineural hearing loss. MATERIALS AND METHODS:Patients with unilateral Menière disease (n = 32) and unilateral idiopathic sudden sensorineural hearing loss (n = 11) imaged with delayed postcontrast 3D-FLAIR MR imaging were retrospectively studied. Signal intensities of the medulla and perilymph of the cochlear basal turns of both ears in each patient were measured in a blinded fashion. Cochlea/medulla ratios were calculated for each ear as a surrogate for blood-labyrinth barrier permeability. The ears were segregated by clinical diagnosis. RESULTS: Cochlea/medulla ratio was higher in symptomatic ears of patients with Menière disease (12.6 ± 7.4) than in patients with idiopathic sudden sensorineural hearing loss (5.7 ± 2.0) and asymptomatic ears of patients with Menière disease (8.0 ± 3.1), indicating increased blood-labyrinth barrier permeability in Menière disease ears. The differences in cochlea/medulla ratio between symptomatic and asymptomatic ears were significantly higher in Menière disease than in idiopathic sudden sensorineural hearing loss. Asymptomatic ears in patients with Menière disease showed higher cochlea/medulla ratio than symptomatic and asymptomatic ears in patients with idiopathic sudden sensorineural hearing loss. CONCLUSIONS: Increased cochlea/medulla ratio indicates increased blood-labyrinth barrier permeability in Menière disease compared with idiopathic sudden sensorineural hearing loss. Increased cochlea/medulla ratio in asymptomatic ears of patients with Menière disease also suggests an underlying systemic cause of Menière disease and may provide a pathophysiologic biomarker.
Authors: Ali R Sepahdari; Gail Ishiyama; Nopawan Vorasubin; Kevin A Peng; Michael Linetsky; Akira Ishiyama Journal: Clin Imaging Date: 2014-10-16 Impact factor: 1.605
Authors: K Baráth; B Schuknecht; A Monge Naldi; T Schrepfer; C J Bockisch; S C A Hegemann Journal: AJNR Am J Neuroradiol Date: 2014-02-13 Impact factor: 3.825
Authors: Allen F Marshall; Valerie L Jewells; Peter Kranz; Yeuh Z Lee; Weili Lin; Carlton J Zdanski Journal: Otolaryngol Head Neck Surg Date: 2010-02 Impact factor: 3.497
Authors: M Yamazaki; S Naganawa; M Tagaya; H Kawai; M Ikeda; M Sone; M Teranishi; H Suzuki; T Nakashima Journal: AJNR Am J Neuroradiol Date: 2011-12-15 Impact factor: 3.825
Authors: Johann Le Floc'h; Winston Tan; Ravindra S Telang; Srdjan M Vlajkovic; Alfred Nuttall; William D Rooney; Beau Pontré; Peter R Thorne Journal: J Magn Reson Imaging Date: 2013-04-15 Impact factor: 4.813
Authors: J M van Steekelenburg; A van Weijnen; L M H de Pont; O D Vijlbrief; C C Bommeljé; J P Koopman; B M Verbist; H M Blom; S Hammer Journal: AJNR Am J Neuroradiol Date: 2020-02-06 Impact factor: 3.825
Authors: S Nahmani; A Vaussy; C Hautefort; J-P Guichard; A Guillonet; E Houdart; A Attyé; M Eliezer Journal: AJNR Am J Neuroradiol Date: 2020-03-19 Impact factor: 3.825
Authors: Michael Eliezer; Charles Maquet; Julien Horion; André Gillibert; Michel Toupet; Benoit Bolognini; Nicolas Magne; Laureline Kahn; Charlotte Hautefort; Arnaud Attyé Journal: Eur Radiol Date: 2018-11-09 Impact factor: 5.315
Authors: Mohammad N Kayyali; Alexander C Wright; Andrew J Ramsey; Jason A Brant; Joel M Stein; Bert W O'Malley; Daqing Li Journal: Nanomedicine Date: 2017-10-24 Impact factor: 5.307
Authors: G Conte; L Caschera; S Calloni; S Barozzi; F Di Berardino; D Zanetti; C Scuffi; E Scola; C Sina; F Triulzi Journal: AJNR Am J Neuroradiol Date: 2018-10-18 Impact factor: 3.825